DK1042278T3 - 1,3-disubstituerede urinstoffer som ACAT inhibitorer samt fremgangsmåde til fremstilling deraf - Google Patents

1,3-disubstituerede urinstoffer som ACAT inhibitorer samt fremgangsmåde til fremstilling deraf

Info

Publication number
DK1042278T3
DK1042278T3 DK98961715T DK98961715T DK1042278T3 DK 1042278 T3 DK1042278 T3 DK 1042278T3 DK 98961715 T DK98961715 T DK 98961715T DK 98961715 T DK98961715 T DK 98961715T DK 1042278 T3 DK1042278 T3 DK 1042278T3
Authority
DK
Denmark
Prior art keywords
disubstituted ureas
preparation
acat inhibitors
isocyanates
enzyme
Prior art date
Application number
DK98961715T
Other languages
Danish (da)
English (en)
Inventor
Ludmila Schmidtova
Marian Zemanek
Vladimir Oremus
Vendelin Smahovsky
Viera Faberova
Ivan Kakalik
Original Assignee
Slovakofarma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma As filed Critical Slovakofarma As
Application granted granted Critical
Publication of DK1042278T3 publication Critical patent/DK1042278T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C275/36Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with at least one of the oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. N-aryloxyphenylureas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
DK98961715T 1997-12-19 1998-12-16 1,3-disubstituerede urinstoffer som ACAT inhibitorer samt fremgangsmåde til fremstilling deraf DK1042278T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK1751-97A SK282727B6 (sk) 1997-12-19 1997-12-19 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
PCT/SK1998/000019 WO1999032437A1 (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof

Publications (1)

Publication Number Publication Date
DK1042278T3 true DK1042278T3 (da) 2003-06-30

Family

ID=20434795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98961715T DK1042278T3 (da) 1997-12-19 1998-12-16 1,3-disubstituerede urinstoffer som ACAT inhibitorer samt fremgangsmåde til fremstilling deraf

Country Status (18)

Country Link
US (1) US6444691B1 (de)
EP (1) EP1042278B1 (de)
JP (1) JP2001526259A (de)
AT (1) ATE233727T1 (de)
AU (1) AU1697699A (de)
BG (1) BG104537A (de)
CZ (1) CZ299695B6 (de)
DE (1) DE69811949T2 (de)
DK (1) DK1042278T3 (de)
ES (1) ES2194379T3 (de)
HR (1) HRP20000351B1 (de)
HU (1) HUP0004332A3 (de)
PL (1) PL341235A1 (de)
PT (1) PT1042278E (de)
RU (1) RU2216536C2 (de)
SK (1) SK282727B6 (de)
WO (1) WO1999032437A1 (de)
YU (1) YU35100A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
JP2002534468A (ja) 1999-01-13 2002-10-15 バイエル コーポレイション p38キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素
US7928239B2 (en) * 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
AU2003209118A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
WO2003068228A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
CA2520763A1 (en) 2003-04-03 2004-10-21 The Regents Of The University Of California Improved inhibitors for the soluble epoxide hydrolase
PT1636585E (pt) 2003-05-20 2008-03-27 Bayer Pharmaceuticals Corp Diarilureias com actividade inibidora de cinase
US8637553B2 (en) 2003-07-23 2014-01-28 Bayer Healthcare Llc Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
WO2005068420A1 (en) * 2003-12-23 2005-07-28 Esperion Therapeutics, Inc. Urea and thiourea compounds and compositions for cholesterol management and related uses
JP2007532484A (ja) 2004-03-16 2007-11-15 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法
EP1814875A4 (de) 2004-10-20 2010-02-17 Univ California Verbesserte inhibitoren der löslichen epoxidhydrolase
SK287385B6 (sk) 2007-11-27 2010-08-09 Hameln-Rds, A. S. 1,3-Disubstituované močoviny, spôsob ich prípravy a použitia
HRP20090186A2 (hr) 2009-03-31 2010-10-31 Institut Ruđer Bošković Adamantanski bisureidni derivati, metoda priprave i primjena u detekciji aniona
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
CA2791680A1 (en) * 2010-03-01 2011-09-09 Myrexis, Inc. Compounds and therapeutic uses thereof
RU2486893C1 (ru) * 2012-06-13 2013-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный технический университет" (ВолгГТУ) Способ получения бис[3-метил(адамант-1-ил)]мочевин
CN107417478B (zh) * 2017-06-05 2020-05-05 南京师范大学 一种催化氧化羰基化合成不对称二取代脲的方法
CN115677660B (zh) * 2022-10-27 2024-05-03 中国药科大学 苯基脲类化合物及其制备方法、用途和药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3284433A (en) * 1963-07-17 1966-11-08 Merck & Co Inc 4-phenoxy-carbanilides
FR1593586A (de) * 1967-10-17 1970-06-01
DE2246109A1 (de) * 1972-09-20 1974-03-28 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazinderivate, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JP2720053B2 (ja) * 1988-11-09 1998-02-25 チッソ株式会社 新規なジアミノ化合物、ジニトロ化合物、ジオール化合物および製造方法
FR2674522B1 (fr) 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
US5576335A (en) 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
JP3668266B2 (ja) 1994-02-01 2005-07-06 株式会社日清製粉グループ本社 尿素誘導体
CA2161376C (en) 1994-10-27 2005-01-11 Toshiaki Minami Reversible multi-color thermal recording medium

Also Published As

Publication number Publication date
AU1697699A (en) 1999-07-12
HRP20000351B1 (en) 2003-10-31
HUP0004332A3 (en) 2002-11-28
RU2216536C2 (ru) 2003-11-20
US6444691B1 (en) 2002-09-03
DE69811949D1 (de) 2003-04-10
EP1042278B1 (de) 2003-03-05
CZ299695B6 (cs) 2008-10-22
BG104537A (en) 2000-12-29
PL341235A1 (en) 2001-03-26
SK175197A3 (en) 1999-07-12
HUP0004332A2 (hu) 2001-05-28
WO1999032437A1 (en) 1999-07-01
CZ20002297A3 (cs) 2000-11-15
DE69811949T2 (de) 2004-03-04
HRP20000351A2 (en) 2000-12-31
SK282727B6 (sk) 2002-11-06
PT1042278E (pt) 2003-07-31
YU35100A (sh) 2002-10-18
JP2001526259A (ja) 2001-12-18
EP1042278A1 (de) 2000-10-11
ES2194379T3 (es) 2003-11-16
ATE233727T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
DK1042278T3 (da) 1,3-disubstituerede urinstoffer som ACAT inhibitorer samt fremgangsmåde til fremstilling deraf
Reiner Spontaneous reactivation of phosphorylated and carbamylated cholinesterases
ATE377072T1 (de) Neues gen für eine aminosäure-deacetylase mit spezifität für n-acetyl-l-phosphinothricin, ihre isolierung und verwendung
ES2195993T3 (es) Metodo para inhibir la produccion de etileno en plantas.
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
DK0920498T3 (da) Hamster EF-1alfa transskriptionelt, regulatorisk DNA
DK1019368T3 (da) Acylsulfamoylbenzoesyreamider, nytteplantebeskyttelsesmidler indeholdende disse samt fremgangsmåder til deres fremstilling
IE881380L (en) Antiatherosclerotic ureas
BR9500631A (pt) Processo para catalisar a trimerização de um isocianato e/ou sua reação com um composto contendo hidrogenio ativo processo para a preparação de espuma de poliuretano e composição de catalisador
BR9400011A (pt) Processo para catalisar a trimerização de um isocianato e/ou a reação de um isocianato e um composto contendo um hidrogênio reagente, processo para preparar espuma de poliuretano, e composição de catalisador
DE69425940D1 (de) Enzymatische synthese von ceramiden und hybrid-ceramiden
ES2037768T3 (es) Procedimiento para preparar n-(fenil(2,6-disustituido))-ureas y carbamatos inhibidores de acil-coa: colesterol acil-transferasa.
DE69839306D1 (de) Verfahren zur herstellung und reinigung von 9-nitro-20-camptothecin
DE69725014D1 (de) Verfahren zur Herstellung von Aminoepoxiden aus aminoaldehyden und einem in situ erzeugten Halogenomethylorganometallischen Reagenz
ATE169042T1 (de) Verfahren zur herstellung von biuretgruppen- haltigen polyisocyanaten
DE50212185D1 (de) Verfahren zur herstellung von isocyanaten
MX9801513A (es) Procedimiento para fabricar poliisocianatos con estructura de biuret.
BR9602616A (pt) Processo para catalizar a trimerização de um isocianato e/ou sua reação com um composto contendo hidrogênio ativo e composição de espuma de poliuretano
BR9500675A (pt) Processo para catalisar a reação de um poliisocianato consigo mesmo ou com um composto contendo hidrogênio ativo processo para preparação de espuma de poliuretano e composição de catalisador
Sampson et al. On the physical properties and mechanism of action of arylsulfate sulfohydrolase II from Aspergillus oryzae
DE69817692D1 (de) Stabilisator für (Fluoroaryl)boran und Verfahren zur Stabilisierung und Kristallisierung von (Fluoroaryl)boran
ATE276984T1 (de) Nitrierung in einem statischen mikromischer
SU1811161A1 (ru) Способ получения органических изоцианатов
ATE53223T1 (de) Verfahren zur herstellung von polyaminen.
DK1002100T3 (da) Fremgangsmåde til fremstilling og identifikation af nye hydrolaser med forbedrede egenskaber